UF Researchers Develop Genetic Score to Improve Pediatric Cancer Treatments

ALACHUA COUNTY TODAY - January 14, 2022


"Cytarabine must be activated to effectively kill leukemia cells, but the amount of activation varies based on an individual’s genetics,"said Jatinder Lamba, Ph.D., M.Sc., the study’s lead author and a professor of pharmacotherapy and translational research in the UF College of Pharmacy, a part of UF Health, the university’s academic health center. 'We anticipated our score would predict the outcome — and it did — but what was really interesting is that we were able to show if the patient had a low, or detrimental score, the outcome could be improved by augmenting the patient’s therapy." Read Article >>

13 views0 comments